Most Recent

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Tasmanian Devil Antibodies Fight Cancer

Tasmanian Devil Antibodies Fight Cancer

By | May 9, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

0 Comments

image: Breast Milk Primes Gut for Microbes

Breast Milk Primes Gut for Microbes

By | May 5, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

2 Comments

image: Embryo Watch

Embryo Watch

By | May 5, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Observing the Nuclear Pore

Observing the Nuclear Pore

By | May 2, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Fuchs on the Future

Fuchs on the Future

By | May 1, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

0 Comments

image: Instant Messaging

Instant Messaging

By | May 1, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

0 Comments

image: More Than Skin Deep

More Than Skin Deep

By | May 1, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Study: “Dirty” Mice More Humanlike

Study: “Dirty” Mice More Humanlike

By | April 21, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

2 Comments

image: “Hunger Hormone” No More?

“Hunger Hormone” No More?

By | April 20, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

3 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech